DSGN
Design Therapeutics Inc
Price:  
4.15 
USD
Volume:  
64,752.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

DSGN Intrinsic Value

-243.89 %
Upside

Is DSGN undervalued or overvalued?

As of 2025-03-27, the Intrinsic Value of Design Therapeutics Inc (DSGN) is -5.97 USD. This DSGN valuation is based on the model Peter Lynch Fair Value. With the current market price of 4.15 USD, the upside of Design Therapeutics Inc is -243.89%. This means that DSGN is overvalued by 243.89%.

Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.

4.15 USD
Stock Price
-5.97 USD
Intrinsic Value
Intrinsic Value Details

DSGN Intrinsic Value - Valuation Summary

Range Selected Upside
a
Fair Value -5.97 - -5.97 -5.97 -243.89%
DDM - Stable (8.45) - (28.28) (18.37) -542.5%
DDM - Multi (10.10) - (26.76) (14.73) -454.9%

DSGN Intrinsic Value - Key Valuation Metrics

Market Cap (mil) 235.55
Beta 2.30
Outstanding shares (mil) 56.76
Enterprise Value (mil) 235.55
Market risk premium 4.60%
Cost of Equity 9.01%
Cost of Debt 5.00%
WACC 6.45%